Skip to main content
. 2018 Nov 2;38:25–36. doi: 10.1016/j.ebiom.2018.10.069

Fig. 5.

Fig. 5

Sal inhibits HIF-1 α signaling pathway. (A) Protein expression level of HIF-1α after treatment with the protein synthesis inhibitor CHX in PLC/PRF/5 cells. (B) Protein expression level of HIF-1α after treatment with the proteasome inhibitor MG132 in PLC/PRF/5 cells. (C) Protein expression level after incubation with the proteasome inhibitor in PLC/PRF/5 cells. (D) Protein expression level of HIF-1α after overexpression of mutational HIF-1α in PLC/PRF/5 cells. (E-F) Cell migration was measured after overexpression of mutational HIF-1α in PLC/PRF/5 cells. (G-H) Representative images of Transwell cell invasion assays after overexpression of mutational HIF-1α in PLC/PRF/5 cells. (I) The relative IC50 values for OXA of PLC/PRF/5 after overexpression of mutational HIF-1α. Error bars represent the standard deviation of experiments performed in triplicate (*P < .05, **P < .01).